Skip to main content
This block is broken or missing. You may be missing content or you might need to enable the original module.
Home
  • English
  • Svenska
  • Français
  • Deutsch
  • Español
  • Italiano
  • Português

Main sub menu

  • Investors
    • Investor relations
    • The share
    • Rights Issue 2016
    • Financial news
      • Presentations
    • Financials
    • Bolagsstyrning
  • Empleo
    • Trabajar en Recipharm
    • La historia de Recipharm
    • Conozca a nuestros empleados
    • Vacantes actuales
  • Contact
    • Contact us
    • Development services contacts
    • Manufacturing services contacts
    • Locations

Main navigation

  • Development
    • Drug substance
    • Drug product
    • Analytical chemistry
    • Clinical trial material (CTM)
  • Manufacturing
    • Solids
    • Semi-solids
    • Liquids
    • Inhalation
    • Injectables
    • Ophthalmics
  • Solutions
    • Recipharm Pathway to Clinic®
    • Serialisation
  • Learn
  • Press & events
    • Press
    • Events
    • Reports
    • Insights
  • Our story
    • Recipharm in brief
    • Business model
    • Business overview
    • Sustainability
    • Company history

Investor relations

Financial news

Financial information

  • Financial press
  • Financial events
  • Financial reports

Investors

  • Investor relations
  • The share
  • Rights Issue 2016
  • Financial news
    • Presentations
  • Financials
  • Bolagsstyrning
Contact

Contact details

ir@recipharm.com
+46 8 602 52 00

Footer menu

  • Privacy policy
  • Cookies
  • Website terms
  • T&C of sale and delivery
© 2019 Recipharm AB (publ). All rights reserved Stormfors Digitalbyrå